[HTML][HTML] Inhaled corticosteroids and secondary adrenal insufficiency
V Sannarangappa, R Jalleh - The open respiratory medicine …, 2014 - ncbi.nlm.nih.gov
Inhaled corticosteroids (ICS) have been used as first line treatment of asthma for many
decades. ICS are a form of exogenous glucocorticosteroids that can suppress the …
decades. ICS are a form of exogenous glucocorticosteroids that can suppress the …
[HTML][HTML] Adrenal suppression: A practical guide to the screening and management of this under-recognized complication of inhaled corticosteroid therapy
A Ahmet, H Kim, S Spier - Allergy, Asthma & Clinical Immunology, 2011 - Springer
Inhaled corticosteroids (ICSs) are the most effective anti-inflammatory agents available for
the treatment of asthma and represent the mainstay of therapy for most patients with the …
the treatment of asthma and represent the mainstay of therapy for most patients with the …
Inhaled corticosteroids and adrenal insufficiency: prevalence and clinical presentation
M Molimard, PO Girodet, C Pollet, A Fourrier-Réglat… - Drug safety, 2008 - Springer
Objective: Adrenal insufficiency (AI) is a potentially life-threatening condition. It is known that
high doses of inhaled corticosteroids (ICS) can induce systemic adverse effects. Currently …
high doses of inhaled corticosteroids (ICS) can induce systemic adverse effects. Currently …
Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis
LHA Broersen, AM Pereira… - The Journal of …, 2015 - academic.oup.com
Objective: We aimed to estimate pooled percentages of patients with adrenal insufficiency
after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we …
after treatment with corticosteroids for various conditions in a meta-analysis. Secondly, we …
The contribution of oral and inhaled glucocorticoids to adrenal insufficiency in asthma
V Brennan, J Martin-Grace, G Greene, K Heverin… - The Journal of Allergy …, 2022 - Elsevier
Background Exposure to any form of glucocorticoid preparation is associated with a risk of
adrenal insufficiency (AI). Objective To establish the contribution of oral corticosteroid (OCS) …
adrenal insufficiency (AI). Objective To establish the contribution of oral corticosteroid (OCS) …
The use of inhaled corticosteroids and the risk of adrenal insufficiency
Adrenal insufficiency is a potential complication of therapy with an inhaled corticosteroid
(ICS). Although prior studies found the highest risk of adrenal insufficiency with fluticasone, a …
(ICS). Although prior studies found the highest risk of adrenal insufficiency with fluticasone, a …
Inhaled steroids and the risk of adrenal suppression in children
DP Skoner, JD Robinson, BL Angelini… - Expert opinion on drug …, 2002 - Taylor & Francis
Corticosteroids are the mainstay of treatment of all asthma severity levels in adults and
children. With their widespread use comes a responsibility to monitor, understand, and …
children. With their widespread use comes a responsibility to monitor, understand, and …
Adrenal insufficiency associated with long-term use of inhaled steroid in asthma
IS Choi, DW Sim, SH Kim, JW Wui - Annals of Allergy, Asthma & …, 2017 - Elsevier
Background We previously reported that as many as one third of hospitalized patients with
asthma treated with a low to medium daily dose of inhaled steroids (ICSs) for an average of …
asthma treated with a low to medium daily dose of inhaled steroids (ICSs) for an average of …
Oral and inhaled corticosteroids and adrenal insufficiency: a case-control study
Background: Adrenal insufficiency, a well recognised complication of treatment with oral
corticosteroids, has been described in association with inhaled corticosteroid use in over 60 …
corticosteroids, has been described in association with inhaled corticosteroid use in over 60 …
[HTML][HTML] Glucocorticoid withdrawal—an overview on when and how to diagnose adrenal insufficiency in clinical practice
K Pelewicz, P Miśkiewicz - Diagnostics, 2021 - mdpi.com
Glucocorticoids (GCs) are widely used due to their anti-inflammatory and
immunosuppressive effects. As many as 1–3% of the population are currently on GC …
immunosuppressive effects. As many as 1–3% of the population are currently on GC …